English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Targeted sequencing of 351 candidate genes for epileptic encephalopathy in a large cohort of patients

MPS-Authors
There are no MPG-Authors in the publication available
External Resource
No external resources are shared
Fulltext (public)

mgg3235.pdf
(Publisher version), 385KB

Supplementary Material (public)
There is no public supplementary material available
Citation

De Kovel, C. G. F., Brilstra, E. H., van Kempen, M. J., Van't Slot, R., Nijman, I. J., Afawi, Z., et al. (2016). Targeted sequencing of 351 candidate genes for epileptic encephalopathy in a large cohort of patients. Molecular Genetics & Genomic Medicine, 4(5), 568-80. doi:10.1002/mgg3.235.


Cite as: http://hdl.handle.net/11858/00-001M-0000-002B-9C7D-2
Abstract
Background Many genes are candidates for involvement in epileptic encephalopathy (EE) because one or a few possibly pathogenic variants have been found in patients, but insufficient genetic or functional evidence exists for a definite annotation. Methods To increase the number of validated EE genes, we sequenced 26 known and 351 candidate genes for EE in 360 patients. Variants in 25 genes known to be involved in EE or related phenotypes were followed up in 41 patients. We pri- oritized the candidate genes, and followed up 31 variants in this prioritized subset of candidate genes. Results Twenty-nine genotypes in known genes for EE (19) or related diseases (10), dominant as well as recessive or X-linked, were classified as likely pathogenic variants. Among those, likely pathogenic de novo variants were found in EE genes that act dominantly, including the recently identified genes EEF1A2, KCNB1 and the X-linked gene IQSEC2 .A de novo frameshift variant in candi- date gene HNRNPU was the only de novo variant found among the followed- up candidate genes, and the patient’s phenotype was similar to a few recent publication